Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial

Peer Review reports

Original Submission
19 Mar 2018	Submitted	Original manuscript
25 Oct 2018	Reviewed	Reviewer Report - Bethan Copsey
5 Dec 2018	Author responded	Author comments - Sheling Xie
Resubmission - Version 2
5 Dec 2018	Submitted	Manuscript version 2
7 Dec 2018	Reviewed	Reviewer Report - Bethan Copsey
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
17 Jan 2019	Editorially accepted
18 Feb 2019	Article published	10.1186/s13063-019-3204-z

Back to article page